Skip to main content
. 2023 Dec 3;17:74–83. doi: 10.1016/j.xjon.2023.11.019

Table E4.

In-hospital and early readmission outcomes by valve type in unmatched patients who underwent mitral valve replacement for endocarditis

Characteristic All patients N = 4206 B-MVR n = 3132 M-MVR n = 1074 P value
In-hospital mortality 229/4206 (5.4%) 177/3132 (5.7%) 52/1074 (4.9%) .48
LOS, d 21 (14, 33) 21 (14, 34) 20 (13, 31) .15
Index hospitalization cost, USD 100,156.7 ± 76,629.4 101,578.0 ± 71,631.0 95,991.4 ± 89,641.1 <.01
Disposition <.001
 Home health care 1287 (35.6%) 920 (34.2%) 367 (39.9%)
 Routine 892 (24.7%) 606 (22.5%) 286 (31.1%)
 Short-term hospital 86 (2.4%) 66 (2.4%) 20 (2.2%)
 Skilled nursing or intermediate care facility 1268 (35.1%) 1036 (38.5%) 232 (25.2%)
 Against medical advice 76 (2.1%) 63 (2.4%) 13 (1.4%)
30-d readmissions 704 (19.5%) 530 (19.7%) 174 (18.9%) .70
90-d readmissions 923/2979 (31.0%) 701/2188 (32.1%) 222/792 (28.0%) .14
Elective readmission 125/1401 (8.9%) 82/1066 (7.7%) 43/335 (12.8%) .09
Died on readmission 81/1401 (5.8%) 58/1066 (5.4%) 23/335 (7.0%) .48

Data presented as mean ± SD, n (%), or n/N (%). B-MVR, Bioprosthetic mitral valve replacement; M-MVR, mechanical mitral valve replacement; LOS, length of stay.

Chi-square test with Rao & Scott's second-order correction.